MedTrace Logo

Acute Effects of DC7-2, a Meat Derived Octapeptide, on Appetite

NCT03089190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-10-22

No results posted yet for this study

Summary

A double-blind, randomized crossover design with four arms including three experimental conditions and placebo will be applied. After having successfully completed screening procedures, eligible participants will be invited to four separate test days. The test days are separated with at least 7 days, however 4 days can be accepted for logistical reasons. During the entire course of the study, participants must remain weight stable and not change their diet or physical activity level. Significant changes in diet, physical activity level (evaluated by the sub-investigator) or weight change ±3 kg over the course of the study (from screening to completion of the last test day) results in exclusion of that subject.

Conditions

  • Appetite; Lack or Loss, Nonorganic Origin

Interventions

DIETARY_SUPPLEMENT

DC7-2

Effects on appetite

DIETARY_SUPPLEMENT

DC7-2 + potato protein isolate

Effects on appetite

DIETARY_SUPPLEMENT

Potato protein isolate

Effects on appetite

DIETARY_SUPPLEMENT

Placebo

Inactive whey protein, not expected to affect appetite.

Sponsors & Collaborators

  • Arne Astrup

    lead OTHER

Principal Investigators

  • Arne Astrup, Professor, MD DMSc · Department of Nutrition, Exercise and Sports, Research Centre Opus, University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-21
Primary Completion
2017-12-07
Completion
2017-12-07

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03089190 on ClinicalTrials.gov